These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35690246)

  • 21. Targeting thromboinflammation in antiphospholipid syndrome.
    Salet DM; Bekkering S; Middeldorp S; van den Hoogen LL
    J Thromb Haemost; 2023 Apr; 21(4):744-757. PubMed ID: 36696191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is known about pediatric antiphospholipid syndrome?
    Meroni PL; Argolini LM; Pontikaki I
    Expert Rev Hematol; 2016 Oct; 9(10):977-85. PubMed ID: 27615277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The significance of antiphospholipid antibodies tests].
    Otomo K; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):63-70. PubMed ID: 23629425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ARID5B-mediated LINC01128 epigenetically activated pyroptosis and apoptosis by promoting the formation of the BTF3/STAT3 complex in β2GPI/anti-β2GPI-treated monocytes.
    Tan Y; Qiao J; Yang S; Wang Q; Liu H; Liu Q; Feng W; Yang B; Li Z; Cui L
    Clin Transl Med; 2024 Jan; 14(1):e1539. PubMed ID: 38224186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
    Manganelli V; Truglia S; Capozzi A; Alessandri C; Riitano G; Spinelli FR; Ceccarelli F; Mancuso S; Garofalo T; Longo A; Valesini G; Sorice M; Conti F; Misasi R
    Front Immunol; 2019; 10():460. PubMed ID: 30923525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New advances in genomics and epigenetics in antiphospholipid syndrome.
    López-Pedrera C; Cerdó T; Jury EC; Muñoz-Barrera L; Escudero-Contreras A; Aguirre MA; Pérez-Sánchez C
    Rheumatology (Oxford); 2024 Feb; 63(SI):SI14-SI23. PubMed ID: 38320594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
    Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
    Front Immunol; 2019; 10():885. PubMed ID: 31134052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on Antiphospholipid Syndrome: Ten Topics in 2017.
    Cavazzana I; Andreoli L; Limper M; Franceschini F; Tincani A
    Curr Rheumatol Rep; 2018 Mar; 20(3):15. PubMed ID: 29541874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on inflammation in antiphospholipid syndrome.
    Ambati A; Zuo Y; Knight JS
    Curr Opin Rheumatol; 2023 Mar; 35(2):89-97. PubMed ID: 36580355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiphospholipid antibody syndrome].
    Chakoutio V; Ries F
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid syndrome and tissue factor: a thrombotic couple.
    López-Pedrera Ch; Buendía P; Aguirre MA; Velasco F; Cuadrado MJ
    Lupus; 2006; 15(3):161-6. PubMed ID: 16634370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antiphospholipid syndrome in patients with systemic lupus erythematosus.
    Pons-Estel GJ; Andreoli L; Scanzi F; Cervera R; Tincani A
    J Autoimmun; 2017 Jan; 76():10-20. PubMed ID: 27776934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Diagnostic Value of New Additional Antiphospholipid Antibodies in Antiphospholipid Syndrome.
    Khogeer H; Altahan S; Alrehaily A; Sheikh A; Awartani K; Al-Kaff M; Saleh S; Alzahrani H; Alfattani A; Owaidah T
    Ann Clin Lab Sci; 2021 Jul; 51(4):552-556. PubMed ID: 34452895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and management of the antiphospholipid syndrome.
    Chaturvedi S; McCrae KR
    Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo.
    Pierangeli SS; Colden-Stanfield M; Liu X; Barker JH; Anderson GL; Harris EN
    Circulation; 1999 Apr; 99(15):1997-2002. PubMed ID: 10209004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory diagnosis and management challenges in the antiphospholipid syndrome.
    Bertolaccini ML; Khamashta MA
    Lupus; 2006; 15(3):172-8. PubMed ID: 16634372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.
    Sciascia S; Amigo MC; Roccatello D; Khamashta M
    Nat Rev Rheumatol; 2017 Sep; 13(9):548-560. PubMed ID: 28769114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.